<DOC>
	<DOC>NCT01243918</DOC>
	<brief_summary>The main objective of this study is to evaluate the efficiency of the oxygen therapy delivery system Optiflow® compared to 2 others standard oxygen therapy delivery systems (Ospal®, non invasive ventilation).12 immunocompetent patients will compare the successive use of oxygen therapy delivery systems Optiflow®/Ospal® and 12 immunodeficient patients will compare the successive use of systems Optiflow®/Non invasive ventilation.</brief_summary>
	<brief_title>Evaluation of Oxygen Therapy Delivery Systems in Hypoxemic Acute Respiratory Failure</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
	<criteria>Patient hospitalized in the intensive care unit of Nantes University Hospital Signed informed consent Patient with not hypercapnic acute hypoxemic respiratory failure Immunocompetent and immunodeficient patient Age &lt; 18 years Pregnancy Contraindication to non invasive ventilation Allergy to xylocaine Coagulation troubles Tracheotomized patient Urgent indication to intubation Hypercapnic acute respiratory failure Acute pulmonary edema Face or nose malformation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Acute respiratory failure</keyword>
	<keyword>Oxygen therapy delivery systems</keyword>
	<keyword>Non invasive ventilation</keyword>
	<keyword>High concentration mask</keyword>
	<keyword>Hypoxemic pneumonia</keyword>
</DOC>